The latest update is out from Clearside Biomedical (CLSD).
Clearside Biomedical, Inc. is set to engage investors and industry experts with a virtual Suprachoroidal Delivery KOL Webinar on July 24, 2024. The event promises to offer insights into the company’s latest developments, featuring a detailed slide presentation. Interested parties can access the webinar through the company’s website, ensuring that shareholders and potential investors have a convenient opportunity to stay informed about Clearside’s advancements.
For detailed information about CLSD stock, go to TipRanks’ Stock Analysis page.
